Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology
Kevin K. Ogden(Emory University), Hongjie Yuan(Emory University)
Cited by 127
Related Papers
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
|Pharmacological Reviews|2021|676
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects
|Journal of Medical Genetics|2017|254
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers
|The American Journal of Human Genetics|2016|183
Structural Determinants of Agonist Efficacy at the Glutamate Binding Site of N-Methyl-d-Aspartate Receptors
|Molecular Pharmacology|2013|89
Implementation of a Fluorescence-Based Screening Assay Identifies Histamine H3 Receptor Antagonists Clobenpropit and Iodophenpropit as Subunit-Selective N-Methyl-d-Aspartate Receptor Antagonists
|Journal of Pharmacology and Experimental Therapeutics|2010|44